Nisa Investment Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,110
| Closed | -$67K | – | 2666 |
|
|
2022
Q2 | $67K | Buy |
2,110
+600
| +40% | +$19.1K | ﹤0.01% | 1636 |
|
|
2022
Q1 | $52K | Buy |
1,510
+650
| +76% | +$22.4K | ﹤0.01% | 1832 |
|
|
2021
Q4 | $25K | Hold |
860
| – | – | ﹤0.01% | 1888 |
|
|
2021
Q3 | $22 | Sell |
860
-1,350
| -61% | -$35 | ﹤0.01% | 2079 |
|
|
2021
Q2 | $77 | Sell |
2,210
-2,360
| -52% | -$82 | ﹤0.01% | 1815 |
|
|
2021
Q1 | $186 | Buy |
4,570
+1,100
| +32% | +$45 | ﹤0.01% | 1514 |
|
|
2020
Q4 | $150K | Sell |
3,470
-1,100
| -24% | -$47.6K | ﹤0.01% | 1586 |
|
|
2020
Q3 | $252K | Buy |
4,570
+1,100
| +32% | +$60.7K | ﹤0.01% | 1251 |
|
|
2020
Q2 | $219K | Sell |
3,470
-2,405
| -41% | -$152K | ﹤0.01% | 1262 |
|
|
2020
Q1 | $300K | Sell |
5,875
-140
| -2% | -$7.15K | ﹤0.01% | 1082 |
|
|
2019
Q4 | $478K | Sell |
6,015
-4,660
| -44% | -$370K | ﹤0.01% | 1110 |
|
|
2019
Q3 | $518K | Buy |
10,675
+2,130
| +25% | +$103K | ﹤0.01% | 1080 |
|
|
2019
Q2 | $449K | Hold |
8,545
| – | – | ﹤0.01% | 1110 |
|
|
2019
Q1 | $452K | Hold |
8,545
| – | – | ﹤0.01% | 1092 |
|
|
2018
Q4 | $351K | Buy |
8,545
+3,300
| +63% | +$136K | ﹤0.01% | 1105 |
|
|
2018
Q3 | $199K | Buy |
5,245
+70
| +1% | +$2.66K | ﹤0.01% | 1322 |
|
|
2018
Q2 | $234K | Hold |
5,175
| – | – | ﹤0.01% | 1235 |
|
|
2018
Q1 | $302K | Sell |
5,175
-175
| -3% | -$10.2K | ﹤0.01% | 1150 |
|
|
2017
Q4 | $211K | Hold |
5,350
| – | – | ﹤0.01% | 1263 |
|
|
2017
Q3 | $166K | Hold |
5,350
| – | – | ﹤0.01% | 1295 |
|
|
2017
Q2 | $145K | Sell |
5,350
-6,560
| -55% | -$178K | ﹤0.01% | 1297 |
|
|
2017
Q1 | $439K | Buy |
11,910
+11,510
| +2,878% | +$424K | 0.01% | 1073 |
|
|
2016
Q4 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 1845 |
|